SuperworthIDEXX Laboratories EPS IDXX
Diluted earnings per share by quarter and over the last twelve months, from 2009.
- Last 12 months, to Jun 30, 2026
- $14.22
- Latest quarter, Q2 FY26
- $4.27
- +18% on a year earlier
- Fiscal year 2025
- $13.07
- +22% on the year before
IDEXX Laboratories' earnings per share was $14.22 over the twelve months to Jun 30, 2026, up 18% on a year earlier.
In its latest quarter, Q2 FY26, it was $4.27, up 18% on the same quarter a year before.
Over the five fiscal years to FY2025 it grew 14% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $13.07 | +22% |
| FY2024 | $10.67 | +6% |
| FY2023 | $10.07 | +25% |
| FY2022 | $8.03 | −7% |
| FY2021 | $8.61 | +28% |
| FY2020 | $6.71 | +38% |
| FY2019 | $4.88 | +14% |
| FY2018 | $4.27 | +45% |
| FY2017 | $2.94 | +20% |
| FY2016 | $2.45 | +20% |
| FY2015 | $2.05 | +15% |
| FY2014 | $1.78 | +3% |
| FY2013 | $1.74 | +10% |
| FY2012 | $1.58 | +14% |
| FY2011 | $1.39 | +17% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $4.27 | +18% | $14.22 | |
| Q1 FY26 | $3.47 | +17% | $13.58 | |
| Q4 FY25 | $3.08 | +18% | $13.07 | |
| Q3 FY25 | $3.40 | +21% | $12.61 | |
| Q2 FY25 | $3.63 | +49% | $12.01 | |
| Q1 FY25 | $2.96 | +5% | $10.82 | |
| Q4 FY24 | $2.62 | +13% | $10.67 | |
| Q3 FY24 | $2.80 | +11% | $10.37 | |
| Q2 FY24 | $2.44 | −9% | $10.10 | |
| Q1 FY24 | $2.81 | +10% | $10.33 | |
| Q4 FY23 | $2.32 | +13% | $10.07 | |
| Q3 FY23 | $2.53 | +18% | $9.80 |
Against its peers
Companies in Medical - Diagnostics & Research nearest IDEXX Laboratories' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| IDXXIDEXX Laboratories | $14.22 | +18% a year |
| WATWaters | $4.01 | −64% a year |
| IQVIQVIA | $8.06 | +17% a year |
| ILMNIllumina | $5.38 | −32% a year |
| AAgilent Technologies | $5.09 | +19% a year |
| MTDMettler-Toledo International | $44.42 | +12% a year |
| DGXQuest Diagnostics | $9.41 | +18% a year |
| LHLabcorp | $12.09 | +33% a year |
| MEDPMedpace | $17.05 | +27% a year |
| RVTYRevvity | $2.10 | −11% a year |
| DHRDanaher | $5.63 | +20% a year |
| Peer median | $6.84 |
Where IDEXX Laboratories ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on IDEXX Laboratories
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.